Dosidal · United States
us:authorisation:ANDA209010
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
| Market | United States |
|---|---|
| Record | us:authorisation:ANDA209010 (version 1) |
| Level | authorisation |
| Pack code | not anchored |
| Identifiers | fda-application: ANDA209010 |
| Source authority | U.S. Food and Drug Administration |
| Read date | |
| authorisation status | application_number: ANDA209010 original_approval: 2018-12-03 products: brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL dosage_form: TABLET marketing_status: Prescription product_number: 003 route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL dosage_form: TABLET marketing_status: Prescription product_number: 001 route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL dosage_form: TABLET marketing_status: Prescription product_number: 004 route: ORAL; brand_name: AMLODIPINE AND OLMESARTAN MEDOXOMIL dosage_form: TABLET marketing_status: Prescription product_number: 002 route: ORAL state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| authorised channel | state: unknown |
| identity | applicant: SCIEGEN PHARMS application_number: ANDA209010 labelers: Amneal Pharmaceuticals NY LLC; AvKARE; ScieGen Pharmaceuticals, Inc state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| label reference | state: unknown |
| prescription class | marketing_status_terms: Prescription state: current · read 2026-11-15T11:42:22Z · source: U.S. Food and Drug Administration page |
| recalls and notices | state: current · read 2026-11-15T11:42:25Z · source: U.S. Food and Drug Administration page |
| Signature | ES256 over JCS, key dosidal-record-1.9dbf5d530LJOFKt_FcQcDiZaVbftheumaodJVQ7zHnUbCkzc-W7V4klhUNBH-VLbOVR-n7Olpb5FYb_wat0ritNZjJDMeAVerify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json |